RENBP and cancer: Another interesting technology applied in the cancer field is the use of Chimeric Antigen Receptors (CARs), synthetic surface receptors created by the fusion of a single-chain Ag-binding domain derived from an Ab to trans-membrane and intracellular signaling domains [165].